Literature DB >> 200701

Inhibition of lymphocyte proliferation stimulated by lectins and allogeneic cells by normal plasma lipoproteins.

J H Morse, L D Witte, D S Goodman.   

Abstract

Lipoproteins, isolated by sequential flotation at densities 1.006, 1.019, 1.063, and 1.21, were examined for their ability to inhibit human lymphocytes stimulated by allogeneic cells and by lectins (phytohemagglutinin-P and concanavalin A). All the classes of normal plasma lipoproteins inhibited lymphoproliferation when peripheral blood lymphocytes were cultured in autologous, heterologous, or lipoprotein-deficient plasma (d greater than 1.21). The rank order of inhibitory potency was intermediate density lipoprotein (IDL) greater than very low density lipoproteins (VLDL) greater than low density lipoproteins (LDL) greater than high density lipoproteins (HDL), regardless of the mode of stimulation. The concentrations of IDL, VLDL, and LDL required for complete inhibition of stimulated lymphoproliferation were considerably below the levels of each of these lipoproteins normally found in human plasma. In addition, the concentration of HDL required for 50-90% inhibition was in the range of HDL levels normally found in human plasma. Moreover, at relatively higher concentrations, lipoproteins suppressed the incorporation of [3H]thymidine into DNA below the levels seen with reseting, unstimulated lymphocytes. The results suggest that circulating lymphocytes may normally be highly suppressed by the combined effects of all the endogenous lipoproteins and that the lipoproteins may play important roles in vivo in modulating lymphocyte functions and responses.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 200701      PMCID: PMC2181900          DOI: 10.1084/jem.146.6.1791

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  33 in total

1.  Ability of large doses of an alpha-2 plasma protein fraction to inhibit antibody production.

Authors:  J F MOWBRAY
Journal:  Immunology       Date:  1963-05       Impact factor: 7.397

2.  The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum.

Authors:  R J HAVEL; H A EDER; J H BRAGDON
Journal:  J Clin Invest       Date:  1955-09       Impact factor: 14.808

3.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

4.  Cholesterol inhibition of the temporary increase of membrane fluidity of lymphocytes induced by mitogenic lectins.

Authors:  S Toyoshima; T Osawa
Journal:  Exp Cell Res       Date:  1976-10-15       Impact factor: 3.905

5.  A rapid, sensitive, and specific method for the determination of protein in dilute solution.

Authors:  W Schaffner; C Weissmann
Journal:  Anal Biochem       Date:  1973-12       Impact factor: 3.365

6.  Difference in microviscosity induced by different cholesterol levels in the surface membrane lipid layer of normal lymphocytes and malignant lymphoma cells.

Authors:  M Shinitzky; M Inbar
Journal:  J Mol Biol       Date:  1974-01-05       Impact factor: 5.469

7.  In vivo suppression of the primary immune response by a species of low density serum lipoprotein.

Authors:  L K Curtiss; D H DeHeer; T S Edgington
Journal:  J Immunol       Date:  1977-02       Impact factor: 5.422

8.  Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions.

Authors:  M Burstein; H R Scholnick; R Morfin
Journal:  J Lipid Res       Date:  1970-11       Impact factor: 5.922

9.  Inhibition of lymphoproliferation by hyperlipoproteinemic plasma.

Authors:  C C Waddell; O D Taunton; J J Twomey
Journal:  J Clin Invest       Date:  1976-10       Impact factor: 14.808

10.  Regulation of low density lipoprotein receptor activity in freshly isolated human lymphocytes.

Authors:  Y K Ho; S Brown; D W Bilheimer; J L Goldstein
Journal:  J Clin Invest       Date:  1976-12       Impact factor: 14.808

View more
  21 in total

1.  Deficiency of scavenger receptor BI leads to impaired lymphocyte homeostasis and autoimmune disorders in mice.

Authors:  Hong Feng; Ling Guo; Dan Wang; Haiqing Gao; Guihua Hou; Zhong Zheng; Junting Ai; Oded Foreman; Alan Daugherty; Xiang-An Li
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-11       Impact factor: 8.311

Review 2.  The role of apolipoprotein E in Guillain-Barré syndrome and experimental autoimmune neuritis.

Authors:  Hong-liang Zhang; Jiang Wu; Jie Zhu
Journal:  J Biomed Biotechnol       Date:  2010-02-16

3.  Immunosuppression by pulmonary surfactant: mechanisms of action.

Authors:  M L Wilsher; D J Parker; P L Haslam
Journal:  Thorax       Date:  1990-01       Impact factor: 9.139

4.  Inhibition by human serum of lymphocyte proliferation stimulated by purified protein derivative of tuberculin and bacillus Calmette-Guérin.

Authors:  R Herman-Brand; B M Sultzer
Journal:  Infect Immun       Date:  1979-09       Impact factor: 3.441

5.  Immunoregulatory properties of pulmonary surfactant: effect of lung lining fluid on proliferation of human blood lymphocytes.

Authors:  M L Wilsher; D A Hughes; P L Haslam
Journal:  Thorax       Date:  1988-05       Impact factor: 9.139

Review 6.  Regulation of Adaptive Immunity in Health and Disease by Cholesterol Metabolism.

Authors:  Michael B Fessler
Journal:  Curr Allergy Asthma Rep       Date:  2015-08       Impact factor: 4.806

7.  The role of lipoproteins in EBV early antigen induction in Raji cells.

Authors:  M Simon; I Melzner; B Bültmann
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

8.  Immunoregulation by low density lipoproteins in man. Inhibition of mitogen-induced T lymphocyte proliferation by interference with transferrin metabolism.

Authors:  J A Cuthbert; P E Lipsky
Journal:  J Clin Invest       Date:  1984-04       Impact factor: 14.808

9.  Modulation of human lymphocyte responses by low density lipoproteins (LDL): enhancement but not immunosuppression is mediated by LDL receptors.

Authors:  J A Cuthbert; P E Lipsky
Journal:  Proc Natl Acad Sci U S A       Date:  1984-07       Impact factor: 11.205

10.  Oxidative modification of low density lipoprotein (LDL) by activated human monocytes and the cell lines U937 and HL60.

Authors:  M K Cathcart; G M Chisolm; A K McNally; D W Morel
Journal:  In Vitro Cell Dev Biol       Date:  1988-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.